Searched for: in-biosketch:true
person:markad01
The relationship between clinical benefit and receipt of curative therapy for prostate cancer
Raldow, Ann C; Presley, Carolyn J; Yu, James B; Sharma, Richa; Cramer, Laura D; Soulos, Pamela R; Long, Jessica B; Makarov, Danil V; Gross, Cary P
PMCID:3491889
PMID: 22371925
ISSN: 0003-9926
CID: 160251
The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit [Meeting Abstract]
Yu, James B.; Aneja, Sanjay; Makarov, Danil V.; Roberts, Kenneth B.; Gross, Cary P.
ISI:000208892400021
ISSN: 0732-183x
CID: 3158692
The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. [Meeting Abstract]
Yu, James B.; Aneja, Sanjay; Makarov, Danil V.; Roberts, Kenneth B.; Gross, Cary P.
ISI:000208892400109
ISSN: 0732-183x
CID: 3159752
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population
Makarov, Danil V; Desai, Rani A; Yu, James B; Sharma, Richa; Abraham, Nitya; Albertsen, Peter C; Penson, David F; Gross, Cary P
PURPOSE: According to guidelines most men with incident prostate cancer do not require staging imaging. We determined the population level prevalence and correlates of appropriate and inappropriate imaging in this cohort. MATERIALS AND METHODS: We performed a cross-sectional study of men 66 to 85 years old who were diagnosed with prostate cancer in 2004 and 2005 from the SEER (Surveillance, Epidemiology and End Results)-Medicare database. Low risk (no prostate specific antigen greater than 10 ng/ml, Gleason score greater than 7 or clinical stage greater than T2) and high risk (1 or more of those features) groups were formed. Inappropriate imaging was defined as any imaging for men at low risk and appropriate imaging was defined as bone scan for men at high risk as well as pelvic imaging as appropriate. Logistic regression modeled imaging in each group. RESULTS: Of 18,491 men at low risk 45% received inappropriate imaging while only 66% of 10,562 at high risk received appropriate imaging. For patients at low risk inappropriate imaging was associated with increasing clinical stage (T2 vs T1 OR 1.35, 95% CI 1.27-1.44), higher Gleason score (7 vs less than 7 OR 1.80, 95% CI 1.69-1.92), increasing age and comorbidity as well as decreasing education. Appropriate imaging for men at high risk was associated with lower stage (T4, T3 and T2 vs T1 OR 0.63, 95% CI 0.48-0.82, OR 0.67, 95% CI 0.60-0.80 and OR 0.87, 95% CI 0.80-0.86) and with higher Gleason score (greater than 8 and 7 vs less than 7 OR 2.18, 95% CI 1.92-2.48 and 1.51, 95% CI 1.35-1.70, respectively) as well as with younger age, white race, higher income, lower stage and more comorbidity. CONCLUSIONS: We found poor adherence to imaging guidelines for men with incident prostate cancer. Understanding the patterns by which clinicians use imaging for prostate cancer should guide educational efforts as well as research to suggest evidence-based guideline improvements
PMID: 22088337
ISSN: 1527-3792
CID: 146252
FACTORS ASSOCIATED WITH THE EARLY ACQUISITION OF THE SURGICAL ROBOT BY HOSPITALS IN THE UNITED STATES [Meeting Abstract]
Makarov, Danil; Li, Huilin; Yu, James; Makary, Martin; Braithwaite, Scott; Sherman, Scott; Taneja, Samir; Penson, David; Lepor, Herbert; Desai, Rani; Blustein, Jan; Gross, Cary
ISI:000302912500419
ISSN: 0022-5347
CID: 1872512
Robotic surgery claims on United States hospital websites
Jin, Linda X; Ibrahim, Andrew M; Newman, Naeem A; Makarov, Danil V; Pronovost, Peter J; Makary, Martin A
To examine the prevalence and content of robotic surgery information presented on websites of U.S. hospitals. We completed a systematic analysis of 400 randomly selected U.S. hospital websites in June of 2010. Data were collected on the presence and location of robotic surgery information on a hospital's website; use of images or text provided by the manufacturer; use of direct link to manufacturer website; statements of clinical superiority; statements of improved cancer outcome; mention of a comparison group for a statement; citation of supporting data and mention of specific risks. Forty-one percent of hospital websites described robotic surgery. Among these, 37% percent presented robotic surgery on their homepage, 73% used manufacturer-provided stock images or text, and 33% linked to a manufacturer website. Statements of clinical superiority were made on 86% of websites, with 32% describing improved cancer control, and 2% described a reference group. No hospital website mentioned risks. Materials provided by hospitals regarding the surgical robot overestimate benefits, largely ignore risks and are strongly influenced by the manufacturer.
PMID: 22059902
ISSN: 1062-2551
CID: 210842
Prostate cancer: PSA velocity in prostate cancer screening-the debate continues
Borofsky, Michael S; Makarov, Danil V
PMID: 21750502
ISSN: 1759-4820
CID: 136516
Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening
Borofsky, Michael S; Makarov, Danil V
PMCID:3739626
PMID: 21532600
ISSN: 1745-7262
CID: 134909
Racial disparities in prostate cancer treatment: The contribution of inappropriate care [Meeting Abstract]
Presley, C. J.; Raldow, A. C.; Cramer, L. D.; Soulos, P. R.; Long, J. B.; Makarov, D. V.; Yu, J. B.; Gross, C. P.
ISI:000208880300585
ISSN: 0732-183x
CID: 3159552
A new formula for prostate cancer lymph node risk
Yu, James B; Makarov, Danil V; Gross, Cary
INTRODUCTION: The successful treatment of prostate cancer depends on the accurate estimation of the risk of regional lymph node (LN) involvement. The Roach formula (RF) has been criticized as overestimating LN risk. A modification of the RF has been attempted by other investigators using simplified adjustment ratios: the Nguyen formula (NF). METHODS AND MATERIALS: The National Cancer Institute Surveillance, Epidemiology, and End Results database was investigated for patients treated in 2004 through 2006 for whom at least 10 LN were examined at radical prostatectomy, cT1c or cT2 disease, and prostate-specific antigen (PSA) <26 ng/ml (N = 2,930). The Yale formula (YF) was derived from half of the sample (n = 1,460), and validated in the other half (n = 1,470). RESULTS: We identified 2,930 patients. Only 4.6% of patients had LN+, and 72.6% had cT1c disease. Gleason (GS) 8-10 histology was found in 14.4% of patients. The YF for prediction of %LN+ risk is [
PMID: 20594769
ISSN: 1879-355x
CID: 138202